Literature DB >> 7808096

Hypercalcemic crisis.

G W Edelson1, M Kleerekoper.   

Abstract

Hypercalcemic crisis or severe hypercalcemia represents a life-threatening emergency. The most common cause is hypercalcemia of malignancy, although granulomatous diseases, previously undetected primary hyperparathyroidism, medication-induced hypercalcemia, and a few rarer causes may result in this endocrine emergency as well. The clinical presentation and prognosis depend on the acuity of the development of hypercalcemia, the degree of hypercalcemia, and the underlying cause. Certainly, patients with malignancy who develop hypercalcemia superimposed on their already debilitated state are more likely to have a poor outcome than a previously relatively healthy patient with thiazide-induced hypercalcemia, for example. The clinical presentation of patients with hypercalcemic crisis varies depending once again on the underlying cause and degree and rapidity of the hypercalcemia. Most patients experience some constitutional symptoms, neurologic symptoms, gastrointestinal symptoms, and renal manifestations of hypercalcemia. Immediate and effective therapy directed toward the pathophysiology of hypercalcemia is essential. General measures must be implemented to reverse the dehydration, to promote urinary calcium excretion, to avoid prolonged immobilization, and to identify the underlying cause of hypercalcemia. Specific measures directed at inhibiting bone resorption, increasing renal sodium and calcium excretion, and occasionally at decreasing intestinal absorption of calcium (or more specifically blocking vitamin D metabolism) should also be implemented. Obviously the more reversible the underlying cause of hypercalcemia, the more aggressive one should be with the therapy. The literature was reviewed to compile comparative data that practitioners may use in choosing among the various pharmacologic therapies available for the treatment of acute hypercalcemia. Despite all the advances in the field, hypercalcemic crisis still carries a significant mortality risk, although with appropriate therapy with the aforementioned general and specific measures, the calcium level can effectively be lowered in most patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7808096     DOI: 10.1016/s0025-7125(16)30085-2

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

1.  Multiple bony swellings and joint stiffness.

Authors:  R Mittal; V Gupta; S Bhan
Journal:  Postgrad Med J       Date:  1997-06       Impact factor: 2.401

2.  Parathyroid carcinoma presenting as a hyperparathyroid crisis.

Authors:  Alice Hyun-Kyung Tan; Hee Kyung Kim; Mi Yeon Kim; Young Lyun Oh; Jee Soo Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

3.  Kasabach-Merritt syndrome combined with hypercalcemia: A case report.

Authors:  Runying Zou; Fang Peng; Tian Yu; Saizhen Zeng; Yalan You; Keke Chen; Hui Zou; Xin Tian; Chengguang Zhu; Xiangling He
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

4.  Hyperparathyroidism caused by a functional parathyroid cyst.

Authors:  Kunihiro Suzuki; Ayuko Sakuta; Chie Aoki; Yosimasa Aso
Journal:  BMJ Case Rep       Date:  2013-06-21

5.  Functional parathyroid cyst: a rare cause of malignant hypercalcemia with primary hyperparathyroidism-a case report and review of the literature.

Authors:  Areej Khan; Yusra Khan; Shahzad Raza; Ghulam Akbar; Monis Khan; Nauman Diwan; Wajih Rizvi
Journal:  Case Rep Med       Date:  2012-02-15

6.  Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?

Authors:  A Catalano; D Chilà; F Bellone; G Nicocia; G Martino; I Loddo; N Morabito; S Benvenga; S Loddo
Journal:  J Clin Transl Endocrinol       Date:  2018-05-29

7.  Management and surgical treatment of parathyroid crisis secondary to parathyroid tumors: report of four cases.

Authors:  Shakil Ameerudden; Xianghui He
Journal:  Int Med Case Rep J       Date:  2011-08-15

8.  A case report: Giant cystic parathyroid adenoma presenting with parathyroid crisis after Vitamin D replacement.

Authors:  Ali Asghar; Mubasher Ikram; Najmul Islam
Journal:  BMC Endocr Disord       Date:  2012-07-28       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.